|
Volumn 9, Issue 5, 2009, Pages 919-920
|
Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus
|
Author keywords
Heart failure; Human immunodeficiency virus; Left ventricular assist device
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANTIRETROVIRUS AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRAIN NATRIURETIC PEPTIDE;
CREATININE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
HEPARIN;
SODIUM;
WARFARIN;
ADULT;
ANAMNESIS;
ARTICLE;
BLOOD PRESSURE MONITORING;
CARDIOMYOPATHY;
CASE REPORT;
CONTINUOUS INFUSION;
HEART ASSIST DEVICE;
HEART EJECTION FRACTION;
HEART FAILURE;
HEART MUSCLE BIOPSY;
HEART MUSCLE FIBROSIS;
HEART SURGERY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MULTIPLE ORGAN FAILURE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
VIRUS LOAD;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CARDIOMYOPATHY, DILATED;
FATAL OUTCOME;
HEART FAILURE;
HEART-ASSIST DEVICES;
HIV INFECTIONS;
HUMANS;
MALE;
MIDDLE AGED;
PROSTHESIS DESIGN;
PROSTHESIS FAILURE;
TREATMENT OUTCOME;
VENTRICULAR FUNCTION, LEFT;
|
EID: 70350448839
PISSN: 15699293
EISSN: None
Source Type: Journal
DOI: 10.1510/icvts.2009.215244 Document Type: Article |
Times cited : (13)
|
References (3)
|